Welcome to our dedicated page for Nve SEC filings (Ticker: NVEC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to NVE Corporation’s (NASDAQ: NVEC) U.S. Securities and Exchange Commission filings, offering a detailed view of how the company reports its business and financial condition. NVE is a Minnesota corporation in the semiconductor and related device manufacturing industry, focused on spintronic sensors and couplers that use electron spin to acquire, store, and transmit information.
Through its SEC filings, investors can review annual reports on Form 10-K for a comprehensive discussion of the business, risk factors, financial statements, and governance, as referenced in the company’s proxy materials. Quarterly results are frequently communicated via press releases furnished as exhibits to Form 8-K filings under Results of Operations and Financial Condition, which break out revenue between product sales and contract research and development, along with net income and key balance sheet items.
NVE also files current reports on Form 8-K for other material events, such as Board approval of quarterly cash dividends, outcomes of the Annual Meeting of Shareholders, and amendments to significant contracts. One example is an 8-K/A describing Amendment No. 12 to the Supplier Partnering Agreement with Abbott, which extends the agreement term and adjusts pricing.
The company’s definitive proxy statement (DEF 14A) details corporate governance practices, executive compensation, equity compensation plans, and security ownership. It also explains shareholder voting procedures for director elections and advisory resolutions. On this page, AI-powered tools can help summarize lengthy filings, highlight key figures and contractual changes, and make it easier to locate information on dividends, material agreements, and governance topics without reading every line of each document.
NVE Corporation reports modestly higher results for the year ended March 31, 2026. Total revenue reached $26.3 million, up 1.8%, as product sales grew 2.4% and contract R&D declined 11% after certain contracts ended. Gross margin slipped to 79% of revenue from 84% due to a less profitable product mix and more distributor sales.
Operating expenses fell 15%, with research and development down 13% and selling, general, and administrative costs down 18% following resource shifts toward manufacturing and new products. Net income edged up 1% to $15.2 million, and the effective tax rate decreased to 15%, helped by $1.07 million of advanced manufacturing investment tax credits.
NVE ended the year with $1.7 million in cash and $41.8 million in marketable securities, representing about 69% of total assets, and paid $4.00 per share in cash dividends (about $19.3 million). The company continues to focus on spintronics-based sensors, couplers, power products, and MRAM, serving industrial, medical, and automation markets while highlighting risks from key customer dependence, supply-chain concentration, competition, and medical-device liability.
NVE Corporation reported modest full-year growth and stronger fourth-quarter results, and declared a cash dividend. Fourth-quarter fiscal 2026 revenue rose 5% to $7.65 million, driven by a 6% increase in product sales, while net income grew 27% to $4.93 million, or $1.02 per diluted share. For fiscal 2026, revenue increased 1.8% to $26.3 million and net income edged up 1% to $15.2 million, or $3.14 per diluted share. The Board approved a quarterly cash dividend of $1.00 per share, payable May 29, 2026 to shareholders of record on May 18, 2026. NVE highlighted continued strength in its spintronic sensors and couplers business and noted forward‑looking statement risks, including reliance on several large customers and economic conditions in its end markets.
NVE Corp: Vanguard Capital Management files a Schedule 13G reporting 243,227 shares (5.02%) of Common Stock. The filing shows sole dispositive power over 243,227 shares and sole voting power over 32,729 shares. The filing is signed by Ashley Grim on 04/30/2026.
Royce & Associates reports beneficial ownership of 229,297 shares of NVE Corporation, representing 4.74% of the class. The filing states these shares are held "in the ordinary course of business" and that Royce has sole voting and sole dispositive power over the reported shares. The filing is signed by Daniel A. O'Byrne on 04/27/2026.
NVE Corp: The Vanguard Group filed an Amendment No. 2 to a Schedule 13G/A reporting that, following an internal realignment effective January 12, 2026, certain Vanguard subsidiaries will report beneficial ownership separately. The filing states zero shares beneficially owned and 0% of NVE Corp common stock by The Vanguard Group in this amendment. The form is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
NVE Corp President & CEO Daniel A. Baker reported open-market sales of company common stock. On January 27, 2026, he sold 1,155 shares at $74.04 per share. On January 29, 2026, he sold an additional 103 shares at $72.25 per share.
Both transactions involved directly held shares. After these trades, Baker beneficially owns 59,928 shares of NVE Corp common stock directly.
NVE Corp stockholder filed a notice to sell 20,000 shares of common stock under Rule 144. The planned sale, through UBS Financial Services Inc. on Nasdaq, has an aggregate market value of $1,501,000 based on the figures provided and is targeted for around 01/27/2026. Shares outstanding were 4,837,166; this is a baseline figure, not the amount being sold.
The shares to be sold trace back to incentive stock option grants acquired on 03/28/2005 from NVE Corp and later paid for via stock swap transactions on 11/02/2011 (4,837 shares) and 11/05/2012 (18,814 shares). The seller represents that they are not aware of any undisclosed material adverse information about NVE Corp’s current or prospective operations.
NVE Corporation’s quarterly report shows solid third-quarter growth but softer results for the fiscal year to date. For the quarter ended December 31, 2025, revenue rose to $6.2 million from $5.1 million, driven by higher product sales and a sharp increase in contract research and development revenue. Quarterly net income increased to $3.4 million, or $0.70 per diluted share, compared with $3.0 million and $0.63 a year earlier.
For the first nine months of fiscal 2026, revenue was nearly flat at $18.7 million, while net income declined to $10.3 million from $11.2 million as gross margin slipped from 85% to 79% due to a less profitable product mix and more distributor sales. The company remained highly liquid, with $3.4 million in cash and $43.6 million in marketable securities, representing about 73% of total assets, and shareholders’ equity of $58.3 million against minimal liabilities.
NVE continued an aggressive cash-return policy, paying $3.00 per share in dividends during the first nine months and declaring another $1.00 per share dividend payable February 27, 2026. The report adds a new risk factor on higher employment costs from Minnesota’s paid leave law and notes that a key Supplier Partnering Agreement with Abbott Laboratories now runs through December 31, 2027.
NVE Corporation reported its financial results for the quarter ended December 31, 2025, through a press release furnished as an exhibit. The detailed numbers are not included in this text, but the update covers the company’s operations and financial condition for that quarter.
The company also announced that its Board of Directors approved a quarterly cash dividend of $1.00 per share of common stock. The dividend is payable on February 27, 2026 to shareholders of record as of February 2, 2026, providing a direct cash return to current investors on the record date.
Royce & Associates LP, a New York-based investment adviser, reports beneficial ownership of 261,822 shares of NVE Corporation common stock, representing 5.41% of the class as of 12/31/2025. Royce & Associates has sole voting and dispositive power over these shares.
The securities are held in investment accounts of its clients, including registered funds and other managed accounts, and are treated as owned in the ordinary course of business. Royce & Associates certifies the holdings were not acquired and are not held for the purpose of changing or influencing control of NVE. The firm also notes that it and other Franklin Resources affiliates exercise voting and investment powers independently and that Royce & Associates disclaims any pecuniary interest and group status regarding these shares.